@ARTICLE{
author={Jassem Jacek,Pienkowski Tadeusz,Pluzanska Anna,Jelic Svetislav S,Gorbunova Vera,Berzins Juris,Nagykalnai Thomas,Biganzoli Laura,Aloe Alessandra,Astier Ludovic,Munier Stephane},
year={2009},
title={Doxorubicin and Paclitaxel versus Fluorouracil, Doxorubicin and Cyclophosphamide as First-Line Therapy for Women with Advanced Breast Cancer: Long-Term Analysis of the Previously Published Trial},
journal={ONKOLOGIE},
volume={32},
number={8-9},
pages={468-472},
document_type={Article},
} 

@ARTICLE{
author={Jassem Jacek,Pluzanska Anna,Pienkowski Tadeusz,Gershanovitch MA,Uziely B,Jelic Svetislav S,Biganzoli Laura,Gwyther SJ,Aloe Alessandra,Astier Ludovic,Munier Stephane},
year={2004},
title={A randomized phase III multicenter trial of doxorubicin and paclitaxel (AT) versus fluorouracil-doxorubicin-cyclophosphamide (FAC) as first-line therapy metastatic breast cancer (MBC): long-term efficacy and external review of results.},
journal={BREAST CANCER RESEARCH AND TREATMENT},
volume={88},
number={},
pages={S198-S198},
document_type={Meeting Abstract},
}